These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 18666855
1. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation. Moins-Teisserenc H, Busson M, Scieux C, Bajzik V, Cayuela JM, Clave E, de Latour RP, Agbalika F, Ribaud P, Robin M, Rocha V, Gluckman E, Charron D, Socié G, Toubert A. J Infect Dis; 2008 Sep 15; 198(6):818-26. PubMed ID: 18666855 [Abstract] [Full Text] [Related]
2. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Borchers S, Luther S, Lips U, Hahn N, Kontsendorn J, Stadler M, Buchholz S, Diedrich H, Eder M, Koehl U, Ganser A, Mischak-Weissinger E. Transpl Infect Dis; 2011 Jun 15; 13(3):222-36. PubMed ID: 21585633 [Abstract] [Full Text] [Related]
9. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Lugthart G, van Ostaijen-Ten Dam MM, Jol-van der Zijde CM, van Holten TC, Kester MG, Heemskerk MH, Bredius RG, van Tol MJ, Lankester AC. Biol Blood Marrow Transplant; 2014 May 15; 20(5):655-61. PubMed ID: 24462981 [Abstract] [Full Text] [Related]
15. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells. Komatsu H, Kogawa K, Nonoyama S, Inui A, Sogo T, Fujisawa T, Klenerman P. J Med Virol; 2006 Dec 15; 78(12):1616-23. PubMed ID: 17063516 [Abstract] [Full Text] [Related]
16. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Król L, Stuchlý J, Hubáček P, Keslová P, Sedláček P, Starý J, Hrušák O, Kalina T. Bone Marrow Transplant; 2011 Aug 15; 46(8):1089-98. PubMed ID: 21057553 [Abstract] [Full Text] [Related]
17. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L. Bone Marrow Transplant; 2007 Mar 15; 39(5):293-9. PubMed ID: 17262060 [Abstract] [Full Text] [Related]
18. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients. Jaskula E, Dlubek D, Duda D, Bogunia-Kubik K, Mlynarczewska A, Lange A. Biol Blood Marrow Transplant; 2009 Oct 15; 15(10):1296-305. PubMed ID: 19747638 [Abstract] [Full Text] [Related]
20. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. Widmann T, Sester U, Gärtner BC, Schubert J, Pfreundschuh M, Köhler H, Sester M. PLoS One; 2008 Oct 15; 3(11):e3634. PubMed ID: 18982061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]